INSM News and Press, Insmed Inc.

2024-07-17 10:40:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Small cap stocks are e...

2024-07-12 10:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-09 08:00:06 ET Vamil Divan from Guggenheim issued a price target of $95.00 for INSM on 2024-07-09 06:44:00. The adjusted price target was set to $95.00. At the time of the announcement, INSM was trading at $70.05. The overall price target consensus is at $72.91 w...

2024-07-09 07:00:00 ET Summary Biotech indexes lagged broader market indexes in the first half of 2024, and trade at the same level as in early 2022. Biotech valuations are closely tied to the Fed's interest rate policy and are highly correlated to the 10-year yield. Inflation...

2024-07-03 15:05:54 ET More on Insmed Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade) Insmed announces pricing of $650M public offering Insmed intends to raise $500M via equity offering Insmed, Inc. (INSM) Q1 2024 Earnings Call Transcript...

Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference PR Newswire —New Graph Depicting 52-Week FEV1 Data Illustrate Significantly Less Decline in Lung Function for Bren...

2024-06-28 15:00:00 ET More on the markets S&P 500: Stay Invested, But Pay Attention To These Risks SPY: The Upside Is Likely Capped SPY: Rating Downgrade Due To Overvaluation S&P 500 H1 performance: Market cap vs. Equal weight Biden-Trump pre...

2024-06-27 08:27:12 ET More on Insmed Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade) Insmed, Inc. (INSM) Q1 2024 Earnings Call Transcript Read the full article on Seeking Alpha For further details see: Insmed redeems all $225 million...

Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025 PR Newswire BRIDGEWATER, N.J. , June 27, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform t...

2024-06-23 06:52:10 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Read the full article on Seeking Alpha For further details see: Wall Street Breakfast: The Week Ahead